Eligi
Med
Ensayos clínicos
Suscripción
Sobre EligiMed
Ensayos Clínicos de Nefrología | EligiMed
Ensayos clínicos
8.676 ensayos encontrados
Reclutando
Fase 3
ClinicalTrials.gov
A Multicentre, Randomised, Double-blind, Parallel Group, Placebo-controlled Trial to Assess the Effects of Oral TRPC6 Inhibitor BI 764198 Taken Over a 104 Week Treatment Period in Adult and Adolescent Participants With Primary Focal Segmental Glomerulosclerosis (pFSGS) or Genetic FSGS Related to TRPC6 Gene Variants
INTERVENTIONAL
Inicio: 16 de feb de 2026
ID: NCT07220083
Completado
Fase 3
ClinicalTrials.gov
A Prospective, Randomized, Double-Blind, Parallel-Group, Multicenter, Non-inferiority Study Comparing the Efficacy and Safety of Rivaroxaban (BAY 59-7939) With Warfarin for the Prevention of Stroke and Non-Central Nervous System Systemic Embolism in Subjects With Non-Valvular Atrial Fibrillation
INTERVENTIONAL
Inicio: 1 de dic de 2006
ID: NCT00403767
Completado
Fase 3
ClinicalTrials.gov
A Phase III, Randomized, Double-Blind, Active Comparator-Controlled Study to Evaluate the Efficacy and Safety of MK-8228 (Letermovir) Versus Valganciclovir for the Prevention of Human Cytomegalovirus (CMV) Disease in Adult Kidney Transplant Recipients
INTERVENTIONAL
Inicio: 3 de may de 2018
ID: NCT03443869
Reclutando
Fase 3
ClinicalTrials.gov
A Multicenter Rollover Extension Program (REP) to Evaluate the Long-term Safety and Tolerability of Open Label Iptacopan in Adult Participants With Primary IgA Nephropathy Who Have Completed Study CLNP023X2203 or CLNP023A2301
INTERVENTIONAL
Inicio: 20 de sept de 2021
ID: NCT04557462
Completado
Fase 3
ClinicalTrials.gov
Effect of Semaglutide Versus Placebo on the Progression of Renal Impairment in Subjects With Type 2 Diabetes and Chronic Kidney Disease
INTERVENTIONAL
Inicio: 17 de jun de 2019
ID: NCT03819153
Completado
Fase 3
ClinicalTrials.gov
A Phase III, Multicenter, Randomized, Open-Label Study to Evaluate the Efficacy and Safety of Atezolizumab Given in Combination With Cabozantinib Versus Cabozantinib Alone in Patients With Inoperable, Locally Advanced, or Metastatic Renal Cell Carcinoma Who Experienced Radiographic Tumor Progression During or After Immune Checkpoint Inhibitor Treatment
INTERVENTIONAL
Inicio: 28 de jul de 2020
ID: NCT04338269
Activo, no recluta
Fase 3
ClinicalTrials.gov
A Phase III, Randomized, Open-Label, Controlled, Multi-Center, Global Study of First-Line Durvalumab in Combination With Standard of Care Chemotherapy and Durvalumab in Combination With Tremelimumab and Standard of Care Chemotherapy Versus Standard of Care Chemotherapy Alone in Patients With Unresectable Locally Advanced or Metastatic Urothelial Cancer.
INTERVENTIONAL
Inicio: 27 de sept de 2018
ID: NCT03682068
Terminado
Fase 3
ClinicalTrials.gov
A Phase 3b, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of TRC101 in Delaying Chronic Kidney Disease Progression in Subjects With Metabolic Acidosis
INTERVENTIONAL
Inicio: 20 de nov de 2018
ID: NCT03710291
Terminado
Fase 3
ClinicalTrials.gov
A Two-year, Phase III Randomized, Double-blind, Parallel-group, Placebo-controlled Trial to Evaluate the Safety, Efficacy, and Tolerability of 300 mg s.c. Secukinumab Versus Placebo, in Combination With SoC Therapy, in Patients With Active Lupus Nephritis
INTERVENTIONAL
Inicio: 7 de jul de 2020
ID: NCT04181762
Completado
ClinicalTrials.gov
A Retrospective Medical Record Review of First-Line Sunitinib Administration Schedules and Outcomes Among Patients With Metastatic Renal Cell Carcinoma in Latin America
OBSERVATIONAL
Inicio: 13 de dic de 2019
ID: NCT04115189
Reclutando
Fase 2
ClinicalTrials.gov
Cardiovascular Effects of SGLT2 Inhibitors in Hemodialysis Patients: A Phase 2 Randomized Study
INTERVENTIONAL
Inicio: 1 de may de 2025
ID: NCT06929169
Completado
Fase 2
ClinicalTrials.gov
A Phase 1/2 Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate Safety, Tolerability and Efficacy of Multiple Sublingual Microdoses of 5-MeO-DMT in Reducing Symptoms of Depression and/or Anxiety.
INTERVENTIONAL
Inicio: 21 de oct de 2024
ID: NCT06816667
Terminado
Fase 3
ClinicalTrials.gov
Multicenter, Randomized, Double-blind, Placebo-controlled Two Stage Study to Characterize the Efficacy, Safety, Tolerability and Pharmacokinetics of GZ/SAR402671 in Patients at Risk of Rapidly Progressive Autosomal Dominant Polycystic Kidney Disease (ADPKD)
INTERVENTIONAL
Inicio: 4 de oct de 2018
ID: NCT03523728
Completado
Fase 3
ClinicalTrials.gov
A Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter, Event-driven Phase 3 Study to Investigate Efficacy and Safety of Finerenone on the Reduction of Cardiovascular Morbidity and Mortality in Subjects With Type 2 Diabetes Mellitus and the Clinical Diagnosis of Diabetic Kidney Disease in Addition to Standard of Care.
INTERVENTIONAL
Inicio: 17 de sept de 2015
ID: NCT02545049
Completado
Fase 3
ClinicalTrials.gov
A Multicenter, Open-label Study to Evaluate the Safety and Diagnostic Efficacy of Mangoral in Patients With Known or Suspected Focal Liver Lesions and Severe Renal Impairment
INTERVENTIONAL
Inicio: 19 de feb de 2020
ID: NCT04119843
Activo, no recluta
Fase 3
ClinicalTrials.gov
A Phase 3, Randomised, Double-blind, Parallel-group, Event-driven, Cardiovascular Safety Study With BI 456906 Administered Subcutaneously Compared With Placebo in Participants With Overweight or Obesity With Established Cardiovascular Disease (CVD) or Chronic Kidney Disease, and/or at Least Two Weight-related Complications or Risk Factors for CVD
INTERVENTIONAL
Inicio: 20 de nov de 2023
ID: NCT06077864
Completado
Fase 4
ClinicalTrials.gov
A Randomized, Placebo Controlled, Double-Blind Comparative Study Evaluating The Effect of Ramipril On Urinary Protein Excretion In Maintenance Renal Transplant Patients Converted To Sirolimus
INTERVENTIONAL
Inicio: 1 de dic de 2007
ID: NCT00502242
Completado
Fase 2
ClinicalTrials.gov
A Phase II Study to Assess Safety, Efficacy, and Pharmacokinetics of INM004 (Anti-Shiga Toxin) in Pediatric Patients With Hemolytic Uremic Syndrome Associated With Shiga Toxin-producing Escherichia Coli Infection
INTERVENTIONAL
Inicio: 6 de oct de 2022
ID: NCT05569746
Reclutando
ClinicalTrials.gov
Institutional Registries of Rare Diseases at Hospital Italiano de Buenos Aires (HIBA)
OBSERVATIONAL
Inicio: 1 de jul de 2024
ID: NCT06573723
Terminado
Fase 3
ClinicalTrials.gov
A Phase 3, International, Randomised, Double-blind, Placebo-controlled Study to Evaluate the Effect of Sodium Zirconium Cyclosilicate on CKD Progression in Participants With CKD and Hyperkalaemia or at Risk of Hyperkalaemia
INTERVENTIONAL
Inicio: 30 de sept de 2021
ID: NCT05056727
Anterior
1
...
6
7
8
...
434
Siguiente
Filtros